Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics.

Zhang, Weijie; Wang, Hao; Feng, Nan; Li, Yifeng; Gu, Jijie; Wang, Zhuozhi

Zhang, Weijie; Wang, Hao; Feng, Nan; Li, Yifeng; Gu, Jijie; Wang, Zhuozhi.

Afiliación

Zhang W; Biologicals Innovation and Discovery, WuXi Biologicals, 1951 Huifeng West Road, Fengxian District, Shanghai 201400, China.
Wang H; Biologicals Innovation and Discovery, WuXi Biologicals, 1951 Huifeng West Road, Fengxian District, Shanghai 201400, China.
Feng N; Biologicals Innovation and Discovery, WuXi Biologicals, 1951 Huifeng West Road, Fengxian District, Shanghai 201400, China.
Li Y; Technology and Process Development, WuXi Biologicals, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China.
Gu J; Biologicals Innovation and Discovery, WuXi Biologicals, 1951 Huifeng West Road, Fengxian District, Shanghai 201400, China.
Wang Z; Biologicals Innovation and Discovery, WuXi Biologicals, 1951 Huifeng West Road, Fengxian District, Shanghai 201400, China.

Antib Ther ; 6(1): 13-29, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36683767

Palabras clave

antibody; antibody-drug conjugate; bispecific; developability; discovery

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Antib Ther Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google